《Luteolin offers novel therapeutic regimen in rotenone-induced Parkinson disease via modulation of TNF-α/FXMRP/serotonin/tyrosine hydroxylase signaling pathway》, NJPS, 卷 40, 期 2, 页 251–262, 12月 2025, doi: 10.54548/.